These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

883 related items for PubMed ID: 10637445

  • 1. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 2. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 3. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [Abstract] [Full Text] [Related]

  • 4. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 6. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ.
    Exp Neurol; 2005 Jun 24; 193(2):420-6. PubMed ID: 15869944
    [Abstract] [Full Text] [Related]

  • 7. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
    Wang L, Muramatsu S, Lu Y, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Hanazono Y, Kume A, Urano F, Ichinose H, Nagatsu T, Nakano I, Ozawa K.
    Gene Ther; 2002 Mar 24; 9(6):381-9. PubMed ID: 11960314
    [Abstract] [Full Text] [Related]

  • 8. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Mandel RJ, Snyder RO, Leff SE.
    Exp Neurol; 1999 Nov 24; 160(1):205-14. PubMed ID: 10630205
    [Abstract] [Full Text] [Related]

  • 9. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA, Saillour P, Ferrero L, Dedieu JF, Mallet J, Paunio T.
    Gene Ther; 2004 May 24; 11(9):746-56. PubMed ID: 14724667
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
    Natsume A, Mata M, Goss J, Huang S, Wolfe D, Oligino T, Glorioso J, Fink DJ.
    Exp Neurol; 2001 Jun 24; 169(2):231-8. PubMed ID: 11358438
    [Abstract] [Full Text] [Related]

  • 11. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 24; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF, Zhang JL, Large DM, Wilson PE, Gash CR, Thomas TC, Haycock JW, Bing G, Stanford JA, Gash DM, Gerhardt GA.
    J Neurochem; 2004 Jul 24; 90(1):245-54. PubMed ID: 15198683
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA, Su C.
    Exp Neurol; 2002 Apr 24; 174(2):230-42. PubMed ID: 11922664
    [Abstract] [Full Text] [Related]

  • 17. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC, Déglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P.
    Exp Neurol; 2000 Jul 24; 164(1):15-24. PubMed ID: 10877911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
    Kojima H, Abiru Y, Sakajiri K, Watabe K, Ohishi N, Takamori M, Hatanaka H, Yagi K.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):569-73. PubMed ID: 9299553
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.